Loading...
Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive, difficult-to-treat subtype of cancer with a poor prognosis; there is an urgent need for effective, targeted molecular therapies. The cyclin D/cyclin-dependent kinase (CDK)4/6–retinoblastoma protein (Rb) pathway plays a critical role in regulatin...
Na minha lista:
| Udgivet i: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8257068/ https://ncbi.nlm.nih.gov/pubmed/34234565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S310649 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|